Recurrent High Risk Myelodysplastic Syndrome Recruiting Phase 1 Trials for Hydrocortisone cypionate (DB14541)

IndicationStatusPhase
DBCOND0092721 (Recurrent High Risk Myelodysplastic Syndrome)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs